📊 CDRE Key Takeaways
Investment Thesis
Cadre Holdings demonstrates solid operational fundamentals with healthy revenue growth of 7.5% YoY and strong free cash flow generation of $56.8M (9.3% FCF margin). The company maintains excellent financial health with a 3.5x current ratio, robust interest coverage of 41.1x, and moderate leverage at 0.92x debt-to-equity, providing flexibility for strategic investments or debt reduction.
CDRE Strengths
- Strong liquidity position with $122.9M cash and 3.5x current ratio enabling operational flexibility
- Excellent interest coverage ratio of 41.1x indicating minimal financial distress risk
- Robust free cash flow generation of $56.8M with 9.3% FCF margin supporting shareholder returns or growth investments
- Healthy gross margin of 42.5% demonstrating pricing power and operational efficiency in surgical appliances sector
- Moderate leverage of 0.92x debt-to-equity providing balance sheet stability
CDRE Risks
- Revenue growth of 7.5% is modest for a specialized medical devices company, suggesting market maturity or competitive pressures
- Net income flat YoY despite revenue growth indicates margin compression or increased operating expenses requiring investigation
- Long-term debt of $291M represents 37.8% of total assets, limiting financial flexibility despite manageable coverage ratios
- Operating margin of 11.0% is relatively thin for orthopedic/surgical appliances sector, leaving limited buffer for cost increases
Key Metrics to Watch
- Revenue growth rate trend and gross margin stability in coming quarters
- Operating cash flow sustainability and capital expenditure requirements for R&D
- Debt reduction progress and leverage trajectory relative to operating cash generation
- Operating margin expansion opportunities through operational leverage on revenue growth
CDRE Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 3.50x current ratio provides a solid financial cushion.
CDRE Profitability Ratios
CDRE vs Default Sector
How Cadre Holdings, Inc. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CDRE Balance Sheet & Liquidity
CDRE 5-Year Financial Trend
5-Year Trend Summary: Cadre Holdings, Inc.'s revenue has grown significantly by 43% over the 5-year period, indicating strong business expansion. The most recent EPS of $1.02 reflects profitable operations.
CDRE Growth Metrics (YoY)
CDRE Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $109.4M | $3.7M | $0.09 |
| Q2 2025 | $144.3M | $6.9M | $0.30 |
| Q1 2025 | $130.1M | $6.9M | $0.18 |
| Q3 2024 | $109.4M | $3.7M | $0.09 |
| Q2 2024 | $121.1M | $6.9M | $0.29 |
| Q1 2024 | $111.7M | $6.9M | $0.18 |
| Q3 2023 | $111.6M | -$779.0K | $-0.02 |
| Q2 2023 | $118.2M | $4.4M | $0.12 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CDRE Capital Allocation
CDRE SEC Filings
Access official SEC EDGAR filings for Cadre Holdings, Inc. (CIK: 0001860543)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CDRE
What is the AI rating for CDRE?
Cadre Holdings, Inc. (CDRE) has an AI rating of BUY with 78% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CDRE's key strengths?
Strong liquidity position with $122.9M cash and 3.5x current ratio enabling operational flexibility. Excellent interest coverage ratio of 41.1x indicating minimal financial distress risk.
What are the risks of investing in CDRE?
Revenue growth of 7.5% is modest for a specialized medical devices company, suggesting market maturity or competitive pressures. Net income flat YoY despite revenue growth indicates margin compression or increased operating expenses requiring investigation.
What is CDRE's revenue and growth?
Cadre Holdings, Inc. reported revenue of $610.3M.
Does CDRE pay dividends?
Cadre Holdings, Inc. pays dividends, with $15.4M distributed to shareholders in the trailing twelve months.
Where can I find CDRE SEC filings?
Official SEC filings for Cadre Holdings, Inc. (CIK: 0001860543) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CDRE's EPS?
Cadre Holdings, Inc. has a diluted EPS of $1.02.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.